Clinical Focus

• Neurology
• Sleep Disorders
• Sleep Medicine

Administrative Appointments

• President, World Sleep Federation (2011 - 2015)
• President, American Academy of Sleep Medicine (2009 - 2010)
• President, California Sleep Society (2008 - 2010)
• Secretary-Treasurer, American Academy of Sleep Medicine (2006 - 2009)
• Board Of Directors, American Academy of Sleep Medicine (2005 - 2011)

Professional Education

Community and International Work

• APPLES - Apnea Positive-Pressure Long-Term Efficacy Study, Stanford Univ; Harvard Univ; Univ of Arizona; St. Luke's Hospital, MO; St. Mary's Hospital, WA 

Internet Links

• Center for Human Sleep Research

Current Research Interests

Dr. Kushida is a neurologist and sleep specialist who directs several NIH- and industry-sponsored research studies, focused on topics such as the physical features and neurocognitive changes associated with the obstructive sleep apnea syndrome, the epidemiology and treatment of restless legs syndrome/periodic limb movement disorder, primary care sleep education and training, and countermeasures for sleep loss.

Clinical Trials

• MA 09-09: Pediatric Nasal Mask Usability Study Recruiting
• A Clinical Research Study of MK-6096 for Primary Insomnia No longer recruiting
• AERO C009: Provent Device Study Completed
• Apnea Positive Pressure Long-Term Efficacy Study No longer recruiting
• CEPH 4026: C10953/4026/AP/US - Armodafinil Drug Study Completed

Publications

• A method for estimating normative distributions for study-specific populations of clinical trials. Holmes TH, Nichols DA, Thomander D, Kushida CA. Contemp Clin Trials. 2012; 33 (2): 445-9
• Positive airway pressure initiation: a randomized controlled trial to assess the impact of therapy mode and titration process on efficacy, adherence, and outcomes. Kushida CA, Berry RB, Blau A, Crabtree T, Fietze I, Kryger MH, Kuna ST, Pegram GV, Penzel T. Sleep. 2011; 34 (8): 1083-92
• Reliability and validity of two self-administered questionnaires for screening restless legs syndrome in population-based studies. Popat RA, Van Den Eeden SK, Tanner CM, Kushida CA, Rama AN, Black JE, Bernstein A, Kasten M, Chade A, Leimpeter A, Cassidy J, McGuire V, Nelson LM. Sleep Med. 2010; 11 (2): 154-60
• Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial. Walters AS, Ondo WG, Kushida CA, Becker PM, Ellenbogen AL, Canafax DM, Barrett RW. Clin Neuropharmacol. 2009 Nov-Dec; 32 (6): 311-20
• A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome. Kushida CA, Walters AS, Becker P, Thein SG, Perkins AT, Roth T, Canafax D, Barrett RW. Sleep. 2009; 32 (2): 159-68